{"id":"https://openalex.org/W2214712710","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.5140","title":"Correlation of prostate-specific antigen (PSA) levels and survival in men with bone metastatic hormone-refractory prostate cancer (HRPC) and normal alkaline phosphatase (ALK)","display_name":"Correlation of prostate-specific antigen (PSA) levels and survival in men with bone metastatic hormone-refractory prostate cancer (HRPC) and normal alkaline phosphatase (ALK)","publication_year":2007,"publication_date":"2007-06-20","ids":{"openalex":"https://openalex.org/W2214712710","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.5140","mag":"2214712710"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2007.25.18_suppl.5140","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.5140","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.5140","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066816851","display_name":"Wanling Xie","orcid":"https://orcid.org/0000-0001-5995-8000","observed_orcids":["https://orcid.org/0000-0001-5995-8000"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Xie","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017334876","display_name":"Meredith M. Regan","orcid":"https://orcid.org/0000-0002-2428-6109","observed_orcids":["https://orcid.org/0000-0002-2428-6109"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. M. Regan","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113456684","display_name":"M. Nakabayashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Nakabayashi","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078027978","display_name":"William K. Oh","orcid":"https://orcid.org/0000-0001-5113-8147","observed_orcids":["https://orcid.org/0000-0001-5113-8147"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. K. Oh","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210117453"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"18_suppl","first_page":"5140","last_page":"5140"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9672999978065491,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9672999978065491,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.017500000074505806,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prostate-specific-antigen","display_name":"prostate-specific antigen","score":0.9210000038146973},{"id":"https://openalex.org/keywords/alkaline-phosphatase","display_name":"alkaline phosphatase","score":0.9800000190734863},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9789999723434448},{"id":"https://openalex.org/keywords/bone-metastases","display_name":"bone metastasis","score":0.9020000100135803},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9829999804496765},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8180000185966492},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.3610000014305115},{"id":"https://openalex.org/keywords/biochemical-recurrence","display_name":"biochemical recurrence","score":0.4869999885559082},{"id":"https://openalex.org/keywords/prognostic-score","display_name":"prognostic score","score":0.3659999966621399},{"id":"https://openalex.org/keywords/gleason-score","display_name":"Gleason score","score":0.5709999799728394},{"id":"https://openalex.org/keywords/performance-status","display_name":"performance status","score":0.3310000002384186},{"id":"https://openalex.org/keywords/karnofsky-performance-status","display_name":"Karnofsky performance status","score":0.4560000002384186}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.885817289352417},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6892200112342834},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6161870360374451},{"id":"https://openalex.org/C2781406297","wikidata":"https://www.wikidata.org/wiki/Q409450","display_name":"Prostate-specific antigen","level":4,"score":0.593669056892395},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.579893946647644},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5577324032783508},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4605483412742615},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.44225257635116577},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4285440146923065},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4257957339286804},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4074190557003021},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.1310010552406311},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0560280978679657},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2007.25.18_suppl.5140","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.5140","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.5140","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2014322725","https://openalex.org/W2530638569","https://openalex.org/W2591497357","https://openalex.org/W2065793218","https://openalex.org/W2084875245","https://openalex.org/W4233651613","https://openalex.org/W2063113306","https://openalex.org/W2015488922","https://openalex.org/W2051687419","https://openalex.org/W1971379606"],"abstract_inverted_index":{"5140":[0],"Background:":[1],"PSA":[2,25,62,127,172,261,292,359],"and":[3,26,47,95,114,135,144,187,216,243,251,293],"ALK":[4,27,58,98,109,159,186,221,265,294,320,338],"are":[5],"recognized":[6],"factors":[7],"for":[8,41,246,278,286,346],"predicting":[9,344],"survival":[10,29,105,263],"in":[11,74,150,182,190,223,309,321,331,343],"men":[12,347],"with":[13,32,39,94,147,184,192,235,248,334,348,354,362],"metastatic":[14,33,43,350],"HRPC.":[15,34,351],"However,":[16],"few":[17],"studies":[18],"have":[19,205],"evaluated":[20,129],"the":[21,88,139,224,233,268,279,288,310,322,332],"combined":[22],"effects":[23],"of":[24,30,66,90,126,175,198,260,291,312],"on":[28,118,262,295],"patients":[31,37,56,183,204,247,353],"Methods:":[35],"224":[36],"treated":[38],"chemotherapy":[40,176,210],"bone":[42,349],"HRPC":[44],"between":[45,92],"1999":[46],"2006":[48],"were":[49,69],"identified":[50],"from":[51],"an":[52],"institutional":[53,119],"database.":[54],"143":[55,155],"had":[57,168],"as":[59,61,131],"well":[60],"values":[63,146],"at":[64,84,87,173],"start":[65,174],"chemotherapy.":[67,108],"There":[68],"no":[70,258],"statistically":[71,298],"significant":[72,299,341,366],"differences":[73],"baseline":[75],"characteristics":[76],"(including":[77],"age,":[78,287],"Gleason":[79],"score,":[80],"PSA,":[81,253],"clinical":[82],"stage":[83],"diagnosis":[85],"or":[86],"initiation":[89],"chemotherapy)":[91],"groups":[93,116],"without":[96],"available":[97],"(p>0.05).":[99],"The":[100,124,301],"primary":[101],"endpoint":[102],"was":[103,110,128,160,177,211,217,222,240,257,266,297,314,339,360],"overall":[104],"(OS)":[106],"after":[107,201,209,284],"dichotomized":[111],"to":[112,305,326,369],"normal":[113,120,185,225,236,269,323,355],"abnormal":[115],"based":[117],"range":[121,226,270],"(38\u2013126":[122],"U/L).":[123],"effect":[125,259,290],"both":[130],"categorical":[132],"(low,":[133],"median":[134,158,196,238,250],"high":[136,252],"group":[137,234,333],"using":[138],"33%,":[140],"66%":[141],"cut-off":[142],"values)":[143],"continuous":[145],"log":[148],"transformation":[149],"Cox":[151],"regression.":[152],"Results:":[153],"Of":[154],"eligible":[156],"patients,":[157],"159":[161],"U/L":[162],"(range:":[163],"52\u20132,020":[164],"U/L);":[165],"89":[166],"(62%)":[167],"elevated":[169,193,335],"ALK.":[170,194,336],"Median":[171,207],"147":[178],"ng/mL;":[179],"93":[180,203],"ng/mL":[181,189],"171":[188],"those":[191],"With":[195],"follow-up":[197],"30":[199],"months":[200,215,245],"chemotherapy,":[202],"died.":[206],"OS":[208,239,296,345],"15.8":[212],"(range":[213],"0\u201357)":[214],"significantly":[218],"longer":[219],"if":[220,264,319],"(21.3":[227],"vs.":[228,272,274],"14":[229],"months,":[230],"p=0.005).":[231],"For":[232],"ALK,":[237,356],"12.5,":[241],"24.5":[242],"36.9":[244],"low,":[249],"respectively;":[254],"while":[255],"there":[256],"beyond":[267],"(16.5":[271],"11.9":[273],"12.1":[275],"months)":[276],"(p=0.21":[277],"interaction).":[280],"In":[281,352],"multivariable":[282],"analysis":[283],"adjusting":[285],"interaction":[289],"(p=0.02).":[300],"relative":[302],"risk":[303],"due":[304],"one":[306],"unit":[307],"increase":[308],"value":[311],"Ln(PSA)":[313],"0.68":[315],"(95%":[316,328],"CI:":[317,329],"0.51\u20130.92)":[318],"range,":[324],"compared":[325],"1.07":[327],"0.85\u20131.35)":[330],"Conclusions:":[337],"a":[340,357],"factor":[342],"higher":[358],"associated":[361],"improved":[363],"survival.":[364],"No":[365],"financial":[367],"relationships":[368],"disclose.":[370]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}